BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38167558)

  • 1. Interaural and sex differences in the natural evolution of hearing levels in pre-symptomatic and symptomatic carriers of the p.Pro51Ser variant in the COCH gene.
    Moyaert J; Gilles A; Mertens G; Lammers MJW; Gommeren H; Janssens de Varebeke S; Fransen E; Verhaert N; Denys S; van de Berg R; Pennings R; Vanderveken O; Van Rompaey V
    Sci Rep; 2024 Jan; 14(1):184. PubMed ID: 38167558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotype-phenotype Correlation Study in a Large Series of Patients Carrying the p.Pro51Ser (p.P51S) Variant in COCH (DFNA9): Part I-A Cross-sectional Study of Hearing Function in 111 Carriers.
    JanssensdeVarebeke SPF; Moyaert J; Fransen E; Bulen B; Neesen C; Devroye K; van de Berg R; Pennings RJE; Topsakal V; Vanderveken O; Van Camp G; Van Rompaey V
    Ear Hear; 2021 Nov-Dec 01; 42(6):1508-1524. PubMed ID: 34369416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review of hearing and vestibular function in carriers of the Pro51Ser mutation in the COCH gene.
    JanssensdeVarebeke S; Topsakal V; Van Camp G; Van Rompaey V
    Eur Arch Otorhinolaryngol; 2019 May; 276(5):1251-1262. PubMed ID: 30806805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype-Phenotype Correlation Study in a Large Series of Patients Carrying the p.Pro51Ser (p.P51S) Variant in COCH (DFNA9) Part II: A Prospective Cross-Sectional Study of the Vestibular Phenotype in 111 Carriers.
    JanssensdeVarebeke SPF; Moyaert J; Fransen E; Bulen B; Neesen C; Devroye K; van de Berg R; Pennings RJE; Topsakal V; Vanderveken O; Van Camp G; Van Rompaey V
    Ear Hear; 2021 Nov-Dec 01; 42(6):1525-1543. PubMed ID: 34369417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated Cognitive Decline Associated With Hearing Loss and Bilateral Vestibulopathy: Insights From a Prospective Cross-Sectional Study Using the Repeatable Battery for the Assessment of Neuropsychological Status Adjusted for the Hearing Impaired in the DFNA9 Population.
    Gommeren H; Bosmans J; Moyaert J; Mertens G; Cras P; Engelborghs S; Van Ombergen A; Gilles A; Fransen E; van de Berg R; JanssensdeVarebeke S; Van Rompaey V
    Ear Hear; 2023 Jul-Aug 01; 44(4):697-709. PubMed ID: 36607747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive Sensitivity and Concordance of Machine-learning Tools for Diagnosing DFNA9 in a Large Series of p.Pro51Ser Variant Carriers in the COCH-gene.
    Salah M; de Varebeke SJ; Fransen E; Topsakal V; Van Camp G; Van Rompaey V
    Otol Neurotol; 2021 Jun; 42(5):671-677. PubMed ID: 33492061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal sclerosis of semicircular canals with severe DFNA9 hearing impairment caused by a P51S COCH-mutation: is there a link?
    de Varebeke SP; Termote B; Van Camp G; Govaerts PJ; Schepers S; Cox T; Deben K; Ketelslagers K; Souverijns G
    Otol Neurotol; 2014 Jul; 35(6):1077-86. PubMed ID: 24662630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vertical corneal striae in families with autosomal dominant hearing loss: DFNA9/COCH.
    Bischoff AM; Pauw RJ; Huygen PL; Aandekerk AL; Kremer H; Cremers CW; Cruysberg JR
    Am J Ophthalmol; 2007 May; 143(5):847-852. PubMed ID: 17368553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AudioGene: refining the natural history of KCNQ4, GSDME, WFS1, and COCH-associated hearing loss.
    Thorpe RK; Walls WD; Corrigan R; Schaefer A; Wang K; Huygen P; Casavant TL; Smith RJH
    Hum Genet; 2022 Apr; 141(3-4):877-887. PubMed ID: 35038006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Pro51Ser mutation in the COCH gene is associated with late onset autosomal dominant progressive sensorineural hearing loss with vestibular defects.
    de Kok YJ; Bom SJ; Brunt TM; Kemperman MH; van Beusekom E; van der Velde-Visser SD; Robertson NG; Morton CC; Huygen PL; Verhagen WI; Brunner HG; Cremers CW; Cremers FP
    Hum Mol Genet; 1999 Feb; 8(2):361-6. PubMed ID: 9931344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational design of a genomically humanized mouse model for dominantly inherited hearing loss, DFNA9.
    Verdoodt D; van Wijk E; Broekman S; Venselaar H; Aben F; Sels L; De Backer E; Gommeren H; Szewczyk K; Van Camp G; Ponsaerts P; Van Rompaey V; de Vrieze E
    Hear Res; 2024 Feb; 442():108947. PubMed ID: 38218018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hearing and vestibular deficits in the Coch(-/-) null mouse model: comparison to the Coch(G88E/G88E) mouse and to DFNA9 hearing and balance disorder.
    Jones SM; Robertson NG; Given S; Giersch AB; Liberman MC; Morton CC
    Hear Res; 2011 Feb; 272(1-2):42-8. PubMed ID: 21073934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel frameshift variant of COCH supports the hypothesis that haploinsufficiency is not a cause of autosomal dominant nonsyndromic deafness 9.
    Masuda M; Mutai H; Arimoto Y; Nakano A; Matsunaga T
    Biochem Biophys Res Commun; 2016 Jan; 469(2):270-4. PubMed ID: 26631968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homozygote loss-of-function variants in the human COCH gene underlie hearing loss.
    Danial-Farran N; Chervinsky E; Nadar-Ponniah PT; Cohen Barak E; Taiber S; Khayat M; Avraham KB; Shalev SA
    Eur J Hum Genet; 2021 Feb; 29(2):338-342. PubMed ID: 32939038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bi-allelic inactivating variants in the COCH gene cause autosomal recessive prelingual hearing impairment.
    JanssensdeVarebeke SPF; Van Camp G; Peeters N; Elinck E; Widdershoven J; Cox T; Deben K; Ketelslagers K; Crins T; Wuyts W
    Eur J Hum Genet; 2018 Apr; 26(4):587-591. PubMed ID: 29449721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attitudes of Potential Participants Towards Potential Gene Therapy Trials in Autosomal Dominant Progressive Sensorineural Hearing Loss.
    Levie C; Moyaert J; Janssens de Varebeke S; Verdoodt D; Vanderveken OM; Topsakal V; Van Wijk E; de Vrieze E; Pennings R; Van de Berg R; Van Camp G; Ponsaerts P; Van Rompaey V
    Otol Neurotol; 2021 Mar; 42(3):384-389. PubMed ID: 33555744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotype analysis of an Australian DFNA9 family with the 1109N COCH mutation.
    Pauw RJ; Huygen PL; Colditz GM; Cremers CW
    Ann Otol Rhinol Laryngol; 2011 Jun; 120(6):414-21. PubMed ID: 21774451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype-Phenotype Correlations of Pathogenic
    Robijn SMM; Smits JJ; Sezer K; Huygen PLM; Beynon AJ; van Wijk E; Kremer H; de Vrieze E; Lanting CP; Pennings RJE
    Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COCH-related autosomal dominant nonsyndromic hearing loss: a phenotype-genotype study.
    Oh KS; Walls D; Joo SY; Kim JA; Yoo JE; Koh YI; Kim DH; Rim JH; Choi HJ; Kim HY; Yu S; Smith RJ; Choi JY; Gee HY; Jung J
    Hum Genet; 2022 Apr; 141(3-4):889-901. PubMed ID: 34529116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive late-onset sensorineural hearing loss and vestibular impairment with vertigo (DFNA9/COCH): longitudinal analyses in a belgian family.
    Lemaire FX; Feenstra L; Huygen PL; Fransen E; Devriendt K; Van Camp G; Vantrappen G; Cremers CW; Wackym PA; Koss JC
    Otol Neurotol; 2003 Sep; 24(5):743-8. PubMed ID: 14501450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.